Live from the NIH registry
Studies recruiting near Cape Coral right now
Top 25 of 239 recruiting studies, sorted by proximity — each links to its official registry page
Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)
Vulvar Diseases, HPV Infection
Phase 2
Interventional 27 participants sought
Florida Gynecologic Oncology — Fort Myers, Florida (9.7 mi)
· Sponsor: Frantz Viral Therapeutics, LLC
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Ovarian Cancer, Fallopian Tube Cancer
Phase 2
Interventional 270 participants sought
544 — Fort Myers, Florida (9.7 mi)
· Sponsor: Corcept Therapeutics
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Generalized Myasthenia Gravis
Phase 3
Interventional 231 participants sought
Site Number - 1002 — Port Charlotte, Florida (23.7 mi)
· Sponsor: Immunovant Sciences GmbH
Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)
CIN 2/3, HPV Infection
Phase 2
Interventional 78 participants sought
Florida Gynecologic Oncology — Fort Myers, Florida (9.7 mi)
· Sponsor: Frantz Viral Therapeutics, LLC
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Spinal Muscular Atrophy (SMA)
N/A
Observational 700 participants sought
Golisano Children's Hospital of Southwest Florida — Fort Myers, Florida (9.7 mi)
· Sponsor: Novartis Pharmaceuticals
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,900 participants sought
Regional Cancer Center-Lee Memorial Health System — Fort Myers, Florida (9.7 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast Neoplasms, Triple Negative Breast Neoplasms
Phase 3
Interventional 2,400 participants sought
Florida Cancer Specialists - South ( Site 7004) — Fort Myers, Florida (9.7 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
GenesisCare USA - FGO — Fort Myers, Florida (9.7 mi)
· Sponsor: NRG Oncology
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Golisano Children's Hospital of Southwest Florida — Fort Myers, Florida (9.7 mi)
· Sponsor: National Cancer Institute (NCI)
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Fort Myers, Florida (9.7 mi)
· Sponsor: Akero Therapeutics, Inc
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Florida Cancer Specialists - South — Fort Myers, Florida (9.7 mi)
· Sponsor: SCRI Development Innovations, LLC
A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG)
New Onset Generalized Myasthenia Gravis (gMG)
Phase 4
Interventional 35 participants sought
Medsol Clinical Research Center Inc — Port Charlotte, Florida (23.7 mi)
· Sponsor: argenx
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Mitral Valve Regurgitation
N/A
Interventional 1,056 participants sought
HealthPark Medical Center — Fort Myers, Florida (9.7 mi)
· Sponsor: Medtronic Cardiovascular
HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs
Degenerative Disc Disease (DDD)
N/A
Interventional 225 participants sought
Southwest Florida Pain Center — Port Charlotte, Florida (23.7 mi)
· Sponsor: ReGelTec, Inc.
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 1,200 participants sought
Florida Cancer Specialists - South ( Site 7001) — Fort Myers, Florida (9.7 mi)
· Sponsor: Merck Sharp & Dohme LLC
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
Schizophrenia
N/A
Observational 1,500 participants sought
Envision Trials LLC — Bonita Springs, Florida (25.0 mi)
· Sponsor: Bristol-Myers Squibb
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis
Phase 2
Interventional 48 participants sought
Golisano Children's Hospital of Southwest Florida — Fort Myers, Florida (9.7 mi)
· Sponsor: National Cancer Institute (NCI)
A Clinical Study of MK-4208/TERN-701 in Participants With Chronic Myeloid Leukemia (CML) (MK-4208-003/Tern701-1012/CARDINAL)
Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Chronic Myeloid Leukemia, Chronic Phase
Phase 1, Phase 2
Interventional 330 participants sought
Florida Cancer Specialists - South Region Research Office — Fort Myers, Florida (9.7 mi)
· Sponsor: Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 2
Interventional 144 participants sought
Alliance for Multispeciality Research - Fort Myers- Site Number : 8400007 — Fort Myers, Florida (9.7 mi)
· Sponsor: Sanofi
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Solid Tumors
Phase 3
Interventional 588 participants sought
Investigative Site US072 — Fort Myers, Florida (9.7 mi)
· Sponsor: Incyte Corporation
Caris Biorepository Research Protocol
Cancer, Early Detection of Cancer
N/A
Observational 100,000 participants sought
Lee Memorial Health System — Fort Myers, Florida (9.7 mi)
· Sponsor: Caris Science, Inc.
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
Golisano Children's Hospital of Southwest Florida — Fort Myers, Florida (9.7 mi)
· Sponsor: National Cancer Institute (NCI)
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma
Phase 3
Interventional 382 participants sought
Regional Cancer Center-Lee Memorial Health System — Fort Myers, Florida (9.7 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)
Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 600 participants sought
Site 12 — Fort Myers, Florida (9.7 mi)
· Sponsor: Merus B.V.
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
Focal Segmental Glomerulosclerosis
Phase 3
Interventional 286 participants sought
Coastal Nephrology and Associates — Port Charlotte, Florida (23.7 mi)
· Sponsor: Boehringer Ingelheim